Tandem Diabetes Care Inc (NASDAQ: TNDM) is 15.75% higher on its value in year-to-date trading and has touched a low of $13.82 and a high of $53.69 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TNDM stock was last observed hovering at around $33.11 in the last trading session, with the day’s gains setting it 1.13%.
Currently trading at $34.24, the stock is 0.67% and -12.71% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.15 million and changing 3.41% at the moment leaves the stock -9.28% off its SMA200. TNDM registered 123.64% gain for a year compared to 6-month loss of -18.77%. The firm has a 50-day simple moving average (SMA 50) of $39.4518 and a 200-day simple moving average (SMA200) of $37.686825.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -14.12% gain in the last 1 month and extending the period to 3 months gives it a -7.16%, and is 5.81% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.14% over the week and 5.01% over the month.
Tandem Diabetes Care Inc (TNDM) has around 2400 employees, a market worth around $2.24B and $796.00M in sales. Profit margin for the company is -17.15%. Distance from 52-week low is 147.76% and -36.23% from its 52-week high. The company has generated returns on investments over the last 12 months (-20.91%).
The EPS is expected to grow by 49.85% this year
442.0 institutions hold shares in Tandem Diabetes Care Inc (TNDM), with institutional investors hold 115.90% of the company’s shares. The shares outstanding are 65.55M, and float is at 64.95M with Short Float at 14.00%. Institutions hold 115.03% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 11.12 million shares valued at $448.14 million. The investor’s holdings represent 17.1137 of the TNDM Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 7.38 million shares valued at $297.26 million to account for 11.3518 of the shares outstanding. The other top investors are CAPITAL WORLD INVESTORS which holds 3.67 million shares representing 5.6394 and valued at over $147.67 million, while UBS GROUP AG holds 4.2239 of the shares totaling 2.75 million with a market value of $110.61 million.
Tandem Diabetes Care Inc (TNDM) Insider Activity
The most recent transaction is an insider sale by Allen Dick, the company’s Director. SEC filings show that Allen Dick sold 5,000 shares of the company’s common stock on May 30 ’24 at a price of $51.68 per share for a total of $0.26 million. Following the sale, the insider now owns 0.0 shares.
Tandem Diabetes Care Inc disclosed in a document filed with the SEC on Nov 27 ’23 that Allen Dick (Director) bought a total of 5,000 shares of the company’s common stock. The trade occurred on Nov 27 ’23 and was made at $18.96 per share for $94778.0. Following the transaction, the insider now directly holds 19962.0 shares of the TNDM stock.
Still, SEC filings show that on Nov 08 ’23, Vosseller Leigh (EVP & CHIEF FINANCIAL OFFICER) acquired 6,200 shares at an average price of $15.39 for $95395.0. The insider now directly holds 11,860 shares of Tandem Diabetes Care Inc (TNDM).
